In vivo studies on transgenic mouse models of PD in which PGC-1α was either knocked out or genetically disrupted revealed an enhanced vulnerability to the neurodegenerative effects of MPTP and kainic acid, due to a lack of PGC-1α-dependent induction of the antioxidant response [174]. The gene discussed is PPARGC1A; the disease is Parkinson disease.